↓ Skip to main content

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases

Overview of attention for article published in Journal of Hematology & Oncology, March 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 1,198)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
11 news outlets
twitter
1 X user

Citations

dimensions_citation
239 Dimensions

Readers on

mendeley
267 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Published in
Journal of Hematology & Oncology, March 2012
DOI 10.1186/1756-8722-5-12
Pubmed ID
Authors

Véronique Gelsi-Boyer, Mandy Brecqueville, Raynier Devillier, Anne Murati, Marie-Joelle Mozziconacci, Daniel Birnbaum

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 267 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 265 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 47 18%
Researcher 38 14%
Student > Master 34 13%
Other 26 10%
Student > Bachelor 23 9%
Other 42 16%
Unknown 57 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 75 28%
Medicine and Dentistry 70 26%
Agricultural and Biological Sciences 39 15%
Immunology and Microbiology 5 2%
Pharmacology, Toxicology and Pharmaceutical Science 4 1%
Other 12 4%
Unknown 62 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2021.
All research outputs
#494,709
of 22,994,508 outputs
Outputs from Journal of Hematology & Oncology
#23
of 1,198 outputs
Outputs of similar age
#2,341
of 161,325 outputs
Outputs of similar age from Journal of Hematology & Oncology
#1
of 7 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,198 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,325 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them